FDA Safety Alert: Nebulizing Relenza Inhalation Powder
Links shared publicly online about this topic.
- 1,688total visits
FDA Safety Alert: Nebulizing Relenza Inhalation Powder
In a Food and Drug Administration MedWatch released October 9, 2009, GlaxoSmithKline (GSK), the manufacturer of Relenza (zanamivir), received a report of a death of a patient who received the drug solubilized and administered by mechanical …
View full resource at examiner.com
Tags: Flu Medication, Drug, FDA, Relenza, GlaxoSmithKline
Most Recently Shared on October 10, 2009 at 3:06 am By:
RT @bactiman63: FDA Safety Alert: Nebulizing Relenza Inhalation Powder - http://shar.es/1d4Kd
FDA Alert: Relenza (zanamivir) Inhalation Powder
drugs.com — “FDA Alert: Relenza (zanamivir) Inhalation Powder” View full resource at drugs.com
Most Recently Shared on October 9, 2009 at 10:18 pm By:
FDA Alert - GSK and FDA Warn Against Nebulization of Relenza (zanamivir) Inhalation Powder - http://bit.ly/2f9w7Q
Advertisement
